MyAverix Finance
US · Healthcare
Biotech Medics Ne (BMCS)
Drug Manufacturers - Specialty & Generic
Biotech Medics Ne (BMCS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BMCS
Biotech Medics Ne (BMCS) — FAQ
What is BMCS's P/E ratio?
The price-to-earnings (P/E) ratio for Biotech Medics Ne (BMCS) is 18.00 (data as of 2026-03-23).
Does Biotech Medics Ne pay a dividend?
Dividend yield is not available in the current snapshot for Biotech Medics Ne (BMCS). Check the MyAverix Finance app for the latest dividend data.
What sector is Biotech Medics Ne in?
Biotech Medics Ne (BMCS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is BMCS listed on?
BMCS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.